PRECISION BIOSCIENCES INC — Director's Dealing 2019

Sep 25, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-09-23

Reporting Person: KANE MATTHEW R. (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-23	Common Stock	M	10000	$1.18	Acquired	1812427	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-23	Employee Stock Option (Right to Buy)	$1.18	M	10000	Disposed	2027-03-23	Common Stock (10000)	Direct
2019-09-23	Employee Stock Option (Right to Buy)	$9.46	A	262252	Acquired	2029-09-22	Common Stock (262252)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8067	Indirect

Footnotes

F1: Securities are held by Chelsea Lynam, the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

F2: The option vested as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of each successive three-month period over the 36 months following such date.

F3: The option vests as to 25% of the underlying shares on April 1, 2020 and vests in equal installments at the end of each successive three-month period over the 36 months following such date.